Epidemiology and Management of Pediatric Anaphylaxis and Allergy in the Pediatric Emergency Department of Montpellier

NCT05112367 | Unknown

• 1 other identifier: RECHMPL21_0613
• Study Type: observational
• Target: 2,500
• Locations: 1 country
• Sites: 1

Brief Summary

Anaphylaxis is a severe life-threatening reaction following exposure to an antigen. Its incidence is progressively increasing in the general population over years, especially among children. The diagnosis can be difficult, and recommendations for follow up and prescription for an emergency kit are rarely provided after emergency visit. The Investigators will evaluate the management of pediatric anaphylaxis and clinical signs of allergy in the pediatric emergency department of Montpellier University Hospital

Conditions

Anaphylaxis; Allergy

Keywords

Children; Emergency; Epinephrine

Outcome Measures

Primary Outcomes (2)

• Evaluation of the management of pediatric anaphylaxis of allergy

  Evaluation of the management of pediatric anaphylaxis of allergy in the pediatric emergency department of Montpellier University Hospital.

  day 1

• Evaluation of the management of pediatric clinical signs evocative of allergy in the pediatric emergency department of Montpellier University Hospital.

  Evaluation of the management of pediatric clinical signs evocative of allergy in the pediatric emergency department of Montpellier University Hospital.

  day 1

Secondary Outcomes (2)

• Evaluation of an appropriate use of epinephrine

  day 1

• Evaluation of an appropriate use of a possible follow-up of patients after the episode

  day 1

Eligibility Criteria

• Age: 2 Years - 99 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Children consulting in the paediatric emergency department of Montpellier for suspected allergy from 2016 to 2020

You may qualify if:

• Patients evaluated at the Montpellier University Hospital, Allergy Unit ;
• Children consulting for suspected allergy from 2016 to 2020

You may not qualify if:

• \- Patients under legal protection, under guardianship or under curatorship;

Sponsors & Collaborators

• University Hospital, Montpellier: lead

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

RECRUITING

Related Publications (1)

• Clark E, Kase Tanno L, Vo T, Blanc B, Demoly P, Caimmi D. Anaphylaxis management in a French pediatric emergency department: Lessons from the ANA-PED study. Clin Transl Allergy. 2023 Aug;13(8):e12289. doi: 10.1002/clt2.12289.

  PMID: 37632240 DERIVED

MeSH Terms

Conditions

Anaphylaxis; Hypersensitivity; Emergencies

Condition Hierarchy (Ancestors)

Hypersensitivity, Immediate; Immune System Diseases; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Davide CAIMMI

  University Hospital, Montpellier

  STUDY DIRECTOR

Central Study Contacts

Davide CAIMMI, MD

CONTACT

467336112; davide.caimmi@gmail.com

Evangéline CLARK, doctor

CONTACT

467336107; e-clark@chu-montpellier.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 27, 2021
• First Posted: November 8, 2021
• Study Start: October 1, 2021
• Primary Completion: January 1, 2022
• Study Completion: June 1, 2022
• Last Updated: November 8, 2021

Record last verified: 2021-10

Locations

FR (1)